Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Itron

Stocks Showing Improving Market Leadership: Itron Earns 84 RS Rating

Itron shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 84.

Investors Business Daily

Itron Sees IBD RS Rating Rise To 76

A Relative Strength Rating upgrade for Itron shows improving technical performance. Will it continue?

Investors Business Daily

Stocks Flashing Renewed Technical Strength: Itron

A Relative Strength Rating upgrade for Itron shows improving technical performance.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Itron Trying To Close In On Key Technical Benchmark

Itron shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Itron Sees Relative Strength Rating Improve To 74

Itron shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Is Itron Inc. (ITRI) Leading the Charge in Smart Grid Technology?

As smart grids redefine energy management, Itron (ITRI) is leading the charge with billion-dollar deals and next-gen grid solutions. But is this stock primed for sustained growth? Read on to find out….

StockNews.com

3 Smart City Stocks Driving Urban Modernization

The smart city market has strong investment potential due to urbanization, government support, emerging technologies, and sustainable solutions. Given this backdrop, investing in stocks like Johnson Controls (JCI), Itron (ITRI), and American Superconductor (AMSC) could be profitable. Keep reading.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Itron, Stock Of The Day, Breaks Out To Highs On 86% Earnings Jump, Strong Guidance

Itron earnings are booming as utilities and cities are in the midst of an infrastructure push. Thursday's Stock Of The Day broke out.

Investors Business Daily

Stock Chart Notebook: These Two Obscure Breakouts Draw Investor Attention

WestRock and Itron rallied around buy points early Thursday on better-than-expected earnings.

Investors Business Daily

Itron Stock Rating Upgraded; Earnings Rose 326% Last Quarter

A Relative Strength Rating upgrade for Itron stock shows improving technical performance.

Investors Business Daily

Top 3 Stocks “Right at Home” in Building Boom

On Wall Street a market that is hitting on all cylinders, with no storm clouds on the horizon, is known as a Goldilocks market. Both the home and infrastructure building markets, due to a perfect storm of short supply on the one hand and government spending on the other, have…

StockNews.com

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022

Benzinga

Itron's Return On Capital Employed Insights

Pulled from Benzinga Pro data, Itron (NASDAQ:ITRI) posted Q1 earnings of $896.00 thousand, an increase from Q4 of 101.53%. Sales dropped to $475.33 million, a 2.12% decrease between quarters.

Benzinga

Analyst Ratings for Itron

Analysts have provided the following ratings for Itron (NASDAQ:ITRI) within the last quarter:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Itron Q1 Revenue Declines 9%; Margins Shrink Due To Semiconductor Crisis

Itron, Inc (NASDAQ:ITRI) reported a first-quarter FY22 revenue decline of 9% year-on-year to $475 million, missing the consensus of $488.5 million. Device Solutions revenue declined 19% Y/Y to $139.6 million, and Networked Solutions revenue reduced 3% Y/Y to $278.8 million. Outcomes revenue decreased 3% Y/Y to $56.9 million. Bookings were $417 million. The…

Benzinga

Itron: Q1 Earnings Insights

Itron (NASDAQ:ITRI) reported its Q1 earnings results on Monday, May 2, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings Itron beat estimated earnings by 37.5%, reporting an EPS of $0.11 versus an estimate of $0.08.

Benzinga

Preview: Itron's Earnings

Itron (NASDAQ:ITRI) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Itron will report an earnings per share (EPS) of $0.08.

Benzinga

Analyst Ratings For Itron

Analysts have provided the following ratings for Itron (NASDAQ:ITRI) within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Itron's Return on Invested Capital Insights

Benzinga Pro data, Itron (NASDAQ:ITRI) reported Q4 sales of $485.64 million. Earnings fell to a loss of $58.42 million, resulting in a 5684.46% decrease from last quarter.

Benzinga

Itron: Q4 Earnings Insights

Itron (NASDAQ:ITRI) reported its Q4 earnings results on Monday, February 28, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Benzinga

Why Are Itron Shares Trading Lower Today

Itron Inc (NASDAQ:ITRI) reported a fourth-quarter FY21 revenue decline of 8% year-on-year to $485.6 million, missing the consensus of $505.8 million. By segment, Outcomes revenue increased 4%, driven by an increase in software and professional services. Networked Solutions revenue decreased 5%, and Device Solutions revenue fell 16%. Bookings were $1.1 billion, leading to…

Benzinga

Earnings Outlook For Itron

Itron (NASDAQ:ITRI) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that Itron will report an earnings per share (EPS) of $0.19.

Benzinga

Preview: Itron's Earnings

People

Steven AdamsAfter

40 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Investor Business Daily

Rhythm Pharmaceuticals

41 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.